Viewing Study NCT04980859


Ignite Creation Date: 2025-12-24 @ 2:24 PM
Ignite Modification Date: 2025-12-29 @ 9:58 AM
Study NCT ID: NCT04980859
Status: UNKNOWN
Last Update Posted: 2021-07-28
First Post: 2021-07-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation
Sponsor: Nanfang Hospital, Southern Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module